Document is current
Any future updates will be listed below
-
Authors
Schultz, Conrad Uldall Becker
Tupper, Oliver Djurhuus https://orcid.org/0000-0002-8788-6726
Ulrik, Charlotte Suppli
-
Funding
Funding for this research was provided by:
Sanofi Genzyme
Fonden til Lægevidenskabens Fremme
Innovationsfonden
Hvidovre Hospital
- License Information
-
More Information
Article History
Received: 2 May 2022
Accepted: 26 July 2022
First Online: 4 August 2022
Declarations
:
: The study was approved by the ethical committee for the Capital Region of Denmark (H-17025043), the regional data safety committee for the capital region of Denmark (P-2019–712), and The Danish Data Protection Agency (2014–41-3468). All participants signed an informed consent form.
: Not applicable.
: Mr. Schultz has no perceived conflicts of interest. Dr. Tupper reports during the conduct of the study; personal fees from TEVA, outside the submitted work. Dr. Ulrik reports fees for lectures, advisory board meeting etc. from Sanofi, Novartis AZ, GSK, Boehringer-Ingelheim, Chiesi, TEVA and ALK-Abello outside the submitted work.
